Enrichment & Purging of Stem Cells in Non-Hodgkin's Lymphoma

Not Applicable

Completed

• Conditions: Lymphoma, Non-Hodgkin

• Registration Number: NCT00186355
• Lead Sponsor: Stanford University

Brief Summary

To evaluate the role of purging the hematopoietic cell graft on outcomes for non-Hodgkin's Lymphoma.

Detailed Description

To study the use of peripheral blood stem cells which have been treated in an effort to remove tumor cells. The researchers hope to learn whether or not this will be more effective in removing the tumor cells as compared to other methods of purging (the removal of cancer cells).

Study Timeline

• Study Start: 2003-10
• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-09-13
• Study First Posted: 2005-09-16
• Primary Completion: 2007-03
• Study Completion: 2010-02
• Status Verified: 2012-05
• Last Update Submitted: 2012-05-10
• Last Update Posted: 2012-05-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 97

Inclusion Criteria

• relapsed NHL

Exclusion Criteria

• liver dysfunction

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
PCR positivity in peripheral blood cell collections after cyclophosphamide

Secondary Outcome Measures

Name	Time	Method
Enrichment of hematopoietic stem cells

Trial Locations

Locations (1)

Stanford University School of Medicine; 🇺🇸 Stanford, California, United States